8-K Announcements
6Material company update
Jun 11, 2026·SEC
Material company update
Jun 11, 2026·SEC
Material company update
Jun 5, 2026·SEC
VSee Health, Inc.(VSEE)Earnings, Financials & Key Ratios
VSEE•NASDAQ
$0.11
Price updated Jun 25, 2026
AboutVSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.Show more
- Revenue$15M+40.3%
- EBITDA-$7M+88.6%
- Net Income-$15M+74.5%
- EPS (Diluted)-0.73+87.1%
- Gross Margin50.32%-26.9%
- EBITDA Margin-47.4%+91.9%
- Operating Margin-65.55%+89.0%
- Net Margin-100.65%+81.8%
- ROE-541.52%
VSEE Price & Volume
VSee Health, Inc. (VSEE) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Challenge VSee Health Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and solvency constraints
"VSee Health faces significant fundamental headwinds characterized by volatile revenue cycles and a deteriorating gross margin profile that compressed from 74.2% in 2024Q1 to 37.9% in 2026Q1. The company's reliance on external capital is underscored by a persistent inability to generate positive free cash flow, which reached an outflow of $2.5 million in 2026Q1 alone. Investors should remain cautious as the current liquidity position, evidenced by a 0.41 current ratio, suggests limited operational runway to support the company's ongoing, loss-making growth strategy."
Verdict Logic
the company's fundamental instability is highlighted by a net margin of -82.3% in 2026Q1 and a persistent, unsustainable operating burn rate.
VSEE Growth Metrics
VSee Health, Inc. (VSEE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.52%
3 Years31.85%
TTM18.05%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM78.34%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM86.87%
Return on Capital
10 Years-1306.51%
5 Years-1649.6%
3 Years-3297.98%
Last Year-268.03%
VSEE Recent Earnings
VSee Health, Inc. (VSEE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (40%)●Beat Revenue 1/12 qtrs (20%)
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.05+54.5%
$0.11
Rev
$3M-34.2%
$5M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.31-287.5%
$0.08
Rev
$4M-10.8%
$4M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.02+75.0%
$0.08
Rev
$4M-5.2%
$4M
Q4 2025
Oct 15, 2025Metric
Actual
Est
EPS
$0.14-16.7%
$0.12
Rev
$3M-13.1%
$4M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.05vs $0.11+54.5% | $3Mvs $5M-34.2% |
| Q2 2026 | Mar 31, 2026 | $0.31vs $0.08-287.5% | $4Mvs $4M-10.8% |
| Q4 2025 | Nov 14, 2025 | $0.02vs $0.08+75.0% | $4Mvs $4M-5.2% |
| Q4 2025 | Oct 15, 2025 | $0.14vs $0.12-16.7% | $3Mvs $4M-13.1% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for VSee Health, Inc. (VSEE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.11 | $1.8M | -0.15 | 40.27% | -100.65% | -541.52% | — | |
| $7.91 | $1.43B | -6.94 | -1.54% | -6.81% | -12.37% | — | |
| $8.40 | $140.35M | -1.41 | -1.98% | -48.16% | -33.48% | — | |
| $4.90 | $91.95M | 18.15 | 18.78% | 6.37% | 5.47% | — | |
| $5.19 | $869.39M | 129.75 | 22% | 0.49% | 1.03% | — | |
| $19.85 | $3.71B | 20.26 | 13.05% | 30.4% | 19.36% | — |
Compare VSEE vs Peers
VSee Health, Inc. (VSEE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
VSEE SEC Filings & Documents
VSee Health, Inc. (VSEE) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when VSEE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
VSEE Frequently Asked Questions
VSee Health, Inc. (VSEE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is VSee Health, Inc.'s revenue?
VSee Health, Inc. (VSEE) reported $14.5M in revenue for fiscal year 2025. This represents a 112% increase from $6.8M in 2020.
How fast is VSee Health, Inc. growing?
VSee Health, Inc. (VSEE) grew revenue by 40.3% over the past year. This is strong growth.
Is VSEE profitable?
VSee Health, Inc. (VSEE) reported a net loss of $13.4M for fiscal year 2025.
Dividend & Returns
What is VSEE's return on equity?
VSee Health, Inc. (VSEE) has a return on equity (ROE) of -541.5%. Negative ROE indicates the company is unprofitable.
What is VSee Health, Inc.'s free cash flow?
VSee Health, Inc. (VSEE) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.